Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Cash (2020 - 2025)

Historic Change in Cash for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $4.7 million.

  • Journey Medical's Change in Cash rose 42081.32% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 20869.76%. This contributed to the annual value of -$7.1 million for FY2024, which is 5631.03% down from last year.
  • Per Journey Medical's latest filing, its Change in Cash stood at $4.7 million for Q3 2025, which was up 42081.32% from -$777000.0 recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Change in Cash ranged from a high of $27.4 million in Q4 2021 and a low of -$9.1 million during Q2 2023
  • In the last 5 years, Journey Medical's Change in Cash had a median value of -$1.5 million in 2024 and averaged $879052.6.
  • As far as peak fluctuations go, Journey Medical's Change in Cash surged by 52724.98% in 2021, and later plummeted by 43586.21% in 2025.
  • Journey Medical's Change in Cash (Quarter) stood at $27.4 million in 2021, then crashed by 110.54% to -$2.9 million in 2022, then surged by 193.14% to $2.7 million in 2023, then crashed by 180.15% to -$2.2 million in 2024, then surged by 315.91% to $4.7 million in 2025.
  • Its Change in Cash stands at $4.7 million for Q3 2025, versus -$777000.0 for Q2 2025 and $765000.0 for Q1 2025.